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 2 
Abstract  15 
Patterns of selection acting on immune defence genes have recently been the focus 16 
of considerable interest. Yet, when it comes to vertebrates, studies have mainly 17 
focused on the acquired branch of the immune system. Consequently, the direction 18 
and strength of selection acting on genes of the vertebrate innate immune defence 19 
remain poorly understood. Here, we present a molecular analysis of selection on an 20 
important receptor of the innate immune system of vertebrates, the Toll-like receptor 21 
2 (TLR2), across 17 rodent species. Although purifying selection was the prevalent 22 
evolutionary force acting on most parts of the rodent TLR2, we found that codons in 23 
close proximity to pathogen-binding and TLR2-TLR1 heterodimerisation sites have 24 
been subject to positive selection in rodents. This indicates that parasite-mediated 25 
selection is not restricted to acquired immune system genes like the Major 26 
histocompatibility complex (MHC), but also affects innate defence genes. To obtain a 27 
comprehensive understanding of evolutionary processes in host-parasite systems, 28 
both innate and acquired immunity thus need to be considered. 29 
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Introduction   34 
The strength and direction of parasite-mediated selection acting on hosts can vary in 35 
time and space as a result of host-parasite coevolution and / or variation in the 36 
composition of the parasite assemblage. As a result, parasites are often assumed to 37 
be important drivers of genetic diversification within and among host species 38 
(Hedrick, 2002; Woolhouse et al., 2002). In line with this, a number of studies have 39 
demonstrated directional selection (i.e. selective sweeps that favour advantageous 40 
mutations and thereby results in divergence between species (Hughes, 1999)) or 41 
balancing selection (which maintains genetic diversity within species) on immune 42 
defence genes in both plants and animals (Tanaka & Nei, 1989; Tiffin & Moeller, 43 
2006; Obbard et al., 2009). In the case of plants and invertebrates, general patterns 44 
of selection on immune defence genes are beginning to emerge (Tiffin & Moeller, 45 
2006). For example, a recent, comprehensive analysis of immune defence genes 46 
across Drosophila species revealed that pathogen recognition genes, rather than 47 
immune signalling or effector genes, are the primary targets of parasite-mediated 48 
selection (Sackton et al., 2007). However, when it comes to vertebrates, it is still 49 
largely unclear which types of host defence genes are subject to positive selection 50 
from parasites (Tiffin & Moeller, 2006).  51 
The vertebrate immune system consists of two parts, the innate and acquired 52 
immune defence. The innate branch of the immune system is ancient and has 53 
homologous components in both invertebrates and plants (Beutler, 2004). It provides 54 
a fast but generally non-specific defence against parasites. The acquired immune 55 
system, on the other hand, is characterized by high specificity and memory, and 56 
occurs exclusively in vertebrates (Cooper & Alder, 2006). Some acquired immune 57 
defence genes have been shown to be subject to strong selective sweeps and / or 58 
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balancing selection in a wide range of taxa, with the Major histocompatibility complex 59 
(MHC) genes being exceptionally well studied in this context (Apanius et al., 1997; 60 
Hughes & Yeager, 1998; Piertney & Oliver, 2006; Wegner, 2008). 61 
In contrast, patterns of selection acting on vertebrate innate immune genes are less 62 
clear. As reviewed above, studies of selection on defence genes in plants and 63 
invertebrates have shown that innate immunity genes, in particular genes involved in 64 
pathogen recognition, can be subject to positive selection (Jiggins & Kim, 2006; Tiffin 65 
& Moeller, 2006; Sackton et al., 2007; Obbard et al., 2009). Yet, in vertebrates the 66 
presence of a highly specific defence, mediated by the acquired immune system, 67 
might affect the role, and consequently the patterns of selection acting on their 68 
innate immune defence. Indeed, it is often argued that because innate defence 69 
receptors recognize conserved pathogen structures, they should be subject to 70 
purifying (i.e. negative) rather than positive selection (Medzhitov & Janeway, 1997; 71 
Mukherjee et al., 2009). 72 
One of the best-studied types of innate defence receptors are Toll-like receptors 73 
(TLRs) (Vasselon & Detmers, 2002; Takeda et al., 2003). TLRs form an extended 74 
gene family, which has evolved by gene duplication (Zhou et al., 2007). The general 75 
structure of TLRs is characterized by an extracellular domain, which consists of a 76 
number of leucine-rich repeats (LRRs) that are involved in pathogen recognition (Jin 77 
et al., 2007), a transmembrane region, and a highly conserved intracellular 78 
Toll/Interleukin-1 receptor (TIR) domain (Kobe & Kajava, 2001; West et al., 2006). 79 
After binding to a pathogen, TLRs form homo- or heterodimers and initiate an 80 
intracellular signalling cascade, which leads to the activation of transcription factors, 81 
the production of pro-inflammatory cytokines and, ultimately, inflammation in the 82 
infected host tissue (Medzhitov, 2001; Akira & Takeda, 2004). Most mammals have 83 
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10 – 12 different TLRs, each recognizing different ligands (Roach et al., 2005). 84 
TLR2, for example, recognizes lipoproteins from cell walls of bacteria, whereas TLR3 85 
targets double-stranded RNA of viruses (Garantziotis et al., 2008).  86 
Because Toll-like receptors, like MHC molecules, are involved in pathogen 87 
recognition, it has been suggested that they might be involved in coevolutionary 88 
processes with pathogens (Hughes & Friedman, 2008). Indeed, recent studies on 89 
primates have found evidence for positive selection on TLRs (Ferrer-Admetlla et al., 90 
2008; Hughes & Piontkivska, 2008; Wlasiuk et al., 2009; Enard et al., 2010). Yet, in 91 
agreement with the hypothesis that there is strong selection against functional 92 
change in innate immune genes in vertebrates, several studies in humans and 93 
livestock found that TLRs have been subject to purifying selection (Yilmaz et al., 94 
2005; Barreiro et al., 2009; Mukherjee et al., 2009; Seabury et al., 2010). Hence, 95 
analyses of patterns of selection on TLRs have yielded surprisingly mixed results.  96 
To shed further light on the strength and direction of selection acting on the 97 
vertebrate innate immune defence in general, and TLRs in particular, and to identify 98 
putatively positively selected TLR sites, we studied signatures of selection in the 99 
Toll-like receptor 2 (TLR2) gene across 17 rodent species. Genetic polymorphisms in 100 
TLR2 are associated with resistance to a variety of disease causing agents, 101 
including Staphylococcus aureus, Mycobacterium tuberculosis, Mycobacterium 102 
leprae, Treponema pallidum, and Borrelia burgdorferi in humans and lab mice (Cook 103 
et al., 2004; Schröder et al., 2005; Texereau et al., 2005; Garantziotis et al., 2008; 104 
Schröder et al., 2008), which makes TLR2 a particularly good candidate for the study 105 
of selection acting on innate immune defence in wild populations.  106 
 107 
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Material and Methods 108 
Samples 109 
Tissue samples from wild populations of 15 rodent species (Table 1) were obtained 110 
using live-traps (Ugglan Special No1, Grahnab, Gnosjö, Sweden) or from colleagues 111 
working with the species. In addition, we used TLR2 sequences of Mus musculus 112 
(Rodentia, Murinae, NM_011905.3), Rattus norvegicus (Rodentia, Murinae, 113 
NM_198769.2) and Cavia porcellus (Rodentia, Caviinae, ENSCPOG00000025374) 114 
publicly available from GenBank and Ensembl. 115 
 116 
Primer design 117 
Murinae primers were designed using the Mus musculus (NM_011905.3) TLR2 118 
sequence and the program Primer3 (Rozen & Skaletsky, 2000). For the Arvicolinae 119 
primers, we first aligned the Mus musculus and Rattus norvegicus TLR2 sequences 120 
and identified highly conserved regions. Primers designed to anneal to this 121 
conserved part of the TLR2 sequence were then used to amplify the homologous 122 
region in the bank vole (Myodes glareolus). Based on this partial bank vole TLR2 123 
sequence, we designed new bank vole specific primers and performed 5’- and 3’-124 
RACE (Rapid Amplification of C-DNA Ends) with total RNA from bank vole spleen 125 
using the SMART RACE cDNA Amplification Kit (Clontech, Mountain View, CA, 126 
USA). This technique allowed us to obtain the full-length cDNA sequence of the bank 127 
vole TLR2. Specific Arvicolinae primers were then designed based on this bank vole 128 
sequence using the program Primer3 (Rozen & Skaletsky, 2000).  129 
 130 
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DNA amplification and sequencing  131 
Total DNA was extracted from the biopsies following the protocol of Laird et al. 132 
(1991). For each rodent species, we amplified the entire coding region of TLR2 in 133 
two overlapping amplicons. PCR reactions were performed in a total volume of 25 µl 134 
including 25 ng of total genomic DNA, 0.125 mM of each dNTP, 2.0 mM MgCl2, 1x 135 
PCR Buffer (Applied Biosystems, Foster City, CA, USA), 1 mM of each primer, and 136 
2.5 U AmpliTaq DNA polymerase (Applied Biosystems, Foster City, CA, USA) on a 137 
GeneAmp PCR Systems 9700 thermocycler (Applied Biosystems, Foster City, CA, 138 
USA). For the first amplicon we used the primer pairs Mur1TLR2F 5’-139 
MRSGTCAAATCTCAGAGGATG-3’ and Mur1TLR2R 5’-140 
GAGTYACACMKRTAGCTGTCTG-3’ for the Murinae, and Arv1TLR2F 5’-141 
CGTGTTCTGTGGACCTTGTG-3’ and Arv1TLR2R 5’-142 
CTAACATCCAGCACCTCCAG-3’ for the Arvicolinae. For the second amplicon, we 143 
used the primer pairs Mur2TLR2F 5’-CAAACTGRAGACTYTGGAAGC-3’ and 144 
Rod2TLR2R 5’-GAACCTAGGACTTTATTGCAGTTCTC-3’ for the Murinae, and 145 
Arv2TLR2F 5’-CTTGACATCAGCCGGAACAG-3’ and Rod2TLR2R for the 146 
Arvicolinae. Additional internal primers were used for sequencing. 147 
The PCR protocol included an initial denaturation step at 94 °C for 5 minutes, 148 
followed by 35 cycles of denaturation at 94 °C for 30 seconds, annealing at 56 °C for 149 
30 seconds and extension at 72 °C for 150 seconds. The program ended with a final 150 
extension step at 72 °C for 10 minutes. The PCR products were sequenced in both 151 
directions on an ABI Prism 3730 capillary sequencer (Applied Biosystems, Foster 152 
City, CA, USA) using Big Dye terminator v3.1 chemistry (Applied Biosystems, Foster 153 
City, CA, USA).  154 
 155 
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Sequence analysis 156 
Sequences were processed, assembled and aligned using ClustalW in the program 157 
Geneious 5.0. (Drummond et al., 2009). Individual alignments were checked and 158 
improved by eye. Consensus sequences were created and all inconsistencies and 159 
polymorphisms were examined by eye. The intracellular region of TLR2 is very 160 
highly conserved across taxa, we never observed a mismatch between overlapping 161 
amplicons and there was no indication that we amplified more than one locus. 162 
Together, this strongly suggests that sequences obtained from the different rodent 163 
species indeed represent true homologues. The full alignments of the rodent TLR2 164 
sequences are presented in Supplementary material 1. The length of the predicted 165 
TLR2 protein was 782 – 784 amino acids in all sequenced rodent species. 166 
Sequences were submitted to NCBI GenBank (see Table 1 for accession numbers).  167 
 168 
Tests of selection 169 
To test for signatures of past selection in the TLR2 DNA sequence of rodents, we 170 
performed a number of standard tests (see e.g. Yang & Bielawski, 2000; Nielsen, 171 
2005). The established structure and inferred function of the TLR2 protein (Xu et al., 172 
2000; Gautam et al., 2006; Jin et al., 2007) allowed us to make a priori predictions 173 
about which sites are expected to evolve under positive selection (i.e. sites involved 174 
in pathogen recognition), and thus to put our results into a functional perspective. 175 
First, to identify regions that may have evolved under positive selection, we 176 
performed a sliding window analysis of the ratio (KA / KS or ω) of non-synonymous 177 
substitutions per non-synonymous site (KA) to synonymous substitutions per 178 
 9 
synonymous site (KS) along the TLR2 gene of Murinae, Myodini and Arvicolini, 179 
compared to the outgroup Cavia porcellus using DnaSP 5 (Librado & Rozas, 2009). 180 
The Jukes-Cantor correction (JC) was applied when calculating KA and KS. The ratio 181 
was calculated for the entire coding region of TLR2 and was averaged for a window 182 
of 30 bp, with a step size of 10 bp. A ratio (ω) > 1 is indicative of positive selection 183 
(i.e. promoting change at the amino acid level), whereas ω < 1 is indicative of 184 
purifying selection (Nielsen, 2005).  185 
Second, we used the phylogeny-based maximum likelihood analysis of ω as 186 
implemented in the program CODEML of the package PAML 4.3 (Yang, 1997) to 187 
statistically test for positive selection acting on TLR2 codons. We generated log 188 
likelihood values for models where ω is allowed to vary among sites within the 189 
interval 0 – 1 (neutral models), and for models, which allow ω to be > 1 for some 190 
sites (selection models) following Yang et al. (2000). First, we tested if ω differs 191 
among sites by comparing model M0, which assumes a constant ω across all sites to 192 
model M3, which allows ω to vary among sites. To formally test for the presence of 193 
sites evolving under positive selection, we then compared a nearly neutral model of 194 
ω variation (M1a) to a model that allows for positive selection (M2a) (Wong et al., 195 
2004; Yang et al., 2005), and a neutral model M7, which estimates ω with a beta 196 
distribution over the interval 0 – 1 to a selection model M8, which additionally allows 197 
for positively selected sites (ω > 1) (Yang et al., 2000; Yang & Nielsen, 2002). A beta 198 
distribution of ω has been suggested to more accurately reflect the distribution of ω 199 
among sites in biological data (Friedman & Hughes, 2007). Furthermore, we 200 
compared beta model M8a (a special case of M8, which fixes ω of the highest site 201 
class to 1) to M8 (Swanson et al., 2003). We compared the models using likelihood 202 
 10 
ratio tests. Twice the log-likelihood difference (2∆) between models follows a χ2 203 
distribution with the degrees of freedom equal to the difference in the number of 204 
parameters between the models (Yang & Nielsen, 2002). All models were run 205 
multiple times with different starting values for ω to ensure the correct estimation of 206 
the model parameters. The unrooted tree input file (Supplementary material 2) for 207 
these analyses was created by calculating a distance matrix in the program DNAdist 208 
and a tree file in the program NEIGHBOR implemented in the package PHYLIP 209 
(Felsenstein, 2005).  210 
Finally, we used Empirical Bayes approaches implemented in CODEML (Yang, 211 
1997) to infer which sites of the TLR2 sequence may have evolved under positive 212 
selection (Yang et al., 2005). This algorithm estimates for each site the posterior 213 
probability of belonging to one of three site classes: low ω, intermediate ω and high 214 
ω. We considered two different approaches to determine sites under selection, the 215 
naive-empirical Bayes and the Bayes-empirical Bayes method (Yang et al., 2005). 216 
Positive selection was interfered if the posterior probability of ω > 1 for a site was ≥ 217 
0.95.  218 
 219 
Results 220 
The sliding window analysis of the ratio KA / KS along the entire TLR2 coding region 221 
produced a strong peak in LRRs 10 – 11. This signal of positive selection was 222 
repeatable across Murinae, Myodini and Arvicolini (Fig. 1). A second prominent KA / 223 
KS peak was observed in LRR 14 in Murinae and Arvicolini, but not in Myodini (Fig. 224 
1). A high KA / KS can be the result of high KA, low KS, or a combination of both. To 225 
investigate what caused the peaks we observed, we therefore calculated KA and KS 226 
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separately for each of the peak regions and compared these values to the average 227 
KA and KS values over different functional regions of TLR2 (Table 2). It turned out 228 
that both peaks were caused by a combination of high KA and low KS. To evaluate 229 
how extreme the KA and KS at the observed peaks were, we generated 100 random 230 
windows of 30 bp (i.e. the window size of the sliding window analysis) along TLR2, 231 
and calculated KS and KA for each window (Supplementary material 3). In this 232 
generated dataset we did neither observe KA values that were as high, nor KS values 233 
that were as low as at the two observed peaks obtained in the sliding window 234 
analysis (Table 2, Supplementary material 3), indicating that the probability of 235 
observing such extreme values by chance is < 1%.  236 
 In addition to the sliding window analysis, phylogeny-based maximum 237 
likelihood approaches (Yang, 1997) provided evidence that positive selection has 238 
acted on codons of the rodent TLR2 sequence. We detected significant ω 239 
heterogeneity along the TLR2 sequence (Model 0 vs. 3: χ24 = 200.32, P < 0.001) with 240 
68% of the sites evolving under strong purifying selection (ω = 0.06), 32% of the 241 
sites evolving neutrally (ω = 0.88), and 0.5% of the sites evolving under strong 242 
positive selection (ω = 4.8) (Table 3). A first selection test, in which we compared a 243 
nearly neutral model (M1a, two site classes) with a selection model (M2a, three site 244 
classes), did not provide statistical support for positive selection (χ22 = 0, P = 1, Table 245 
3). However, when comparing models that estimate ω with a beta distribution the 246 
selection model M8 (eleven site classes), which allows ω > 1, performed significantly 247 
better than the neutral model M7 (ten site classes), which restricts ω to the interval 0 248 
– 1 (χ22 = 6.66, P = 0.036, Table 3). Furthermore, the comparison of model M8a vs. 249 
M8 (both eleven site classes; (χ21 = 4.34, P = 0.037) provided evidence that ω of the 250 
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highest site class is significantly > 1, and thus that parts of TLR2 are evolving under 251 
positive selection. Selection models did not perform significantly better than neutral 252 
models when analysing Murinae, Arvicolini, and Myodini separately (results not 253 
shown). 254 
To identify specific sites of TLR2 that have likely evolved under positive selection, we 255 
used Empirical Bayes approaches (Yang et al., 2005). Even though both model M8 256 
and model M3 indicated that 0.5 – 0.6% of all TLR2 sites evolve under positive 257 
selection (ω = 4.6, Table 3), which corresponds to 3 – 5 codons, we had the 258 
statistical power to identify only one site, amino acid 354, as being positively 259 
selected with a posterior probability ≥ 0.95 (Table 3, Fig. 2).  260 
 261 
Discussion  262 
Unlike in plants and invertebrates, where it is well documented that positive selection 263 
has shaped innate immunity genes (Jiggins & Kim, 2006; Tiffin & Moeller, 2006; 264 
Sackton et al., 2007; Obbard et al., 2009), it is often assumed that in vertebrates 265 
purifying selection is the predominant selective force acting on the innate branch of 266 
the immune system (Yilmaz et al., 2005; Barreiro et al., 2009; Mukherjee et al., 2009; 267 
Seabury et al., 2010). Nonetheless, a few recent studies have demonstrated that 268 
also in vertebrates positive selection has acted on functionally relevant sites of 269 
innate defence genes (Ferrer-Admetlla et al., 2008; Hughes & Piontkivska, 2008; 270 
Wlasiuk et al., 2009; Enard et al., 2010). In agreement with these latter studies, we 271 
found indication that positive selection has shaped parts of the rodent TLR2 gene.  272 
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Positive selection is predicted to act on regions of immune genes that are involved in 273 
pathogen recognition (e.g. Hughes et al., 1990; Hedrick, 2002; Hughes & Friedman, 274 
2008). In agreement with this prediction, the sliding window analysis of KA / KS along 275 
the TLR2 coding region produced a pronounced signal of positive selection in LRR 276 
10 – 11. This signal of selection was repeatable across all three analysed taxonomic 277 
groups. A second peak was observed in LRR 14 in Murinae and Arvicolini. The 278 
LRRs 10 – 11 regions contain 10 to 13 putative pathogen-binding sites in humans 279 
and lab mice (Jin et al., 2007), and variation in these binding sites might directly 280 
influence the pathogen-binding capacity or specificity of the receptor. LRR14, on the 281 
other hand, contains sites that are involved in the heterodimerisation of TLR2 with 282 
TLR1 (Jin et al., 2007). Interestingly, the common human TLR2 variant Arg753Gln, 283 
which is associated with resistance to late stage Lyme disease (Schröder et al., 284 
2005), also affects TLR2 heterodimerisation (Gautam et al., 2006). This indicates 285 
that even though heterodimerisation sites are not directly involved in pathogen-286 
binding, they might indirectly influence the pathogen-binding ability of the receptor by 287 
changing the conformation of the TLR2 – TLR1 hererodimer structure (Gautam et al., 288 
2006).  289 
Sliding window analyses of KA / KS have been criticised (see e.g. Hughes & 290 
Friedman, 2008; Nozawa et al., 2009; Wolf et al., 2009) because KA / KS peaks could 291 
reflect regions with particularly low KS rather than high KA, something which can 292 
occur by chance given the high variance of KS (Parmley & Hurst, 2007). In such 293 
cases, KA / KS peaks will not be indicative of positive selection. A detailed 294 
examination of our data, however, showed that stochastic variation of KS alone 295 
cannot explain the observed KA / KS peaks. Rather the KA / KS peaks are a result of 296 
both exceptionally high KA as well as exceptionally low KS. An outlier analysis 297 
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demonstrated that such extreme KA and KS values would be expected by chance in < 298 
1%. The reason for the low KS is not entirely clear, but one potential explanation is 299 
that selective sweeps (indicated by the high KA), in combination with a high 300 
recombination rate, have depleted these particular regions of neutral variation. In any 301 
case, the fact that the KA / KS peaks are at least partly a result of high KA, in 302 
combination with the repeatability of the peaks across the analysed clades, and the 303 
location of the peaks in the predicted regions of TLR2 (Jin et al., 2007) provides 304 
strong evidence that the observed KA / KS peaks are indicative of positive selection 305 
rather than chance events.  306 
The notion that positive selection shapes parts of the rodent TLR2 was further 307 
corroborated by phylogeny-based maximum likelihood approaches. Although 68% of 308 
the TLR2 sequence was estimated to evolve under strong purifying selection and 309 
another 32% evolving neutrally, 0.5 – 0.6% of all sites (which corresponds to 3 – 5 310 
amino acids) were found to be shaped by positive selection. Using empirical Bayes 311 
approaches we were able to identify one of these positively selected sites, amino 312 
acid 354. This site is located in LRR 12 in close proximity to both pathogen-binding 313 
and heterodimerisation sites (Jin et al., 2007). The nonsynonymous mutations 314 
observed at this site have led to pronounced changes in the amino acids’ physico-315 
chemical properties (i.e. polarity, charge, volume; Supplementary material 1), which 316 
are thought to be important in the determination of protein structure (Grantham, 317 
1974; Miyata et al., 1979). Such radical changes are expected if natural selection 318 
promotes functional change of proteins, but they are incompatible with the 319 
substitution pattern predicted under relaxed purifying selection (see e.g. Nielsen, 320 
2005). Remarkably, LRR12 showed a very low KA / KS ratio in the sliding window 321 
analysis, indicating that codons in close proximity to amino acid 354 are subject to 322 
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strong purifying selection, and thus that patterns of selection can differ markedly on a 323 
very small scale. 324 
 325 
To conclude, our results indicate that purifying selection is not the only evolutionary 326 
force that has shaped the rodent TLR2 sequence, as a small number of TLR2 327 
codons have evolved under positive selection. There are numerous examples of 328 
single nucleotide polymorphisms having pronounced evolutionary consequences, for 329 
example in genes involved in pathogen virulence (Brault et al., 2007) or pigmentation 330 
(Hoekstra et al., 2004; Rosenblum et al., 2004; Linnen et al., 2009). Since the 331 
positively selected sites in the TLR2 sequence were in close proximity to pathogen-332 
binding and TLR heterodimerisation sites (Jin et al., 2007), it is thus plausible that 333 
functional changes in these regions may have direct consequences for host-334 
pathogen interactions. So far, ecological and evolutionary research into the 335 
interactions between vertebrate hosts and their parasites has almost exclusively 336 
focused on the acquired branch of the immune system (i.e. associations between 337 
host MHC polymorphisms and parasite resistance (Paterson et al., 1998; Wegner et 338 
al., 2003; Meyer-Lucht & Sommer, 2005; Oliver et al., 2009)), whereas the host’s 339 
innate immune defence has received considerably less attention. Associating 340 
putatively positively selected amino acid differences in innate immunity genes with 341 
parasite resistance and tolerance in wild vertebrate populations might thus be a 342 
fruitful endeavour to obtain a more comprehensive understanding of evolutionary 343 
processes in natural host-parasite systems.  344 
Furthermore, future studies will need to examine whether patterns of selection on 345 
TLR2 are exceptional, or if also other members of the Toll-like receptor gene family, 346 
 16 
and other innate immunity genes in general, have been subject to positive selection 347 
during the evolutionary past, and if differences in selection patterns can be 348 
associated with functional difference between immune genes. New technologies 349 
(such as next generation sequencing) will greatly facilitate such comparative studies.  350 
 351 
 352 
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Table legends 365 
 366 
Table 1 Origin of rodent samples, number of sequenced individuals (N) and NCBI 367 
GenBank accession numbers. *Sequences obtained from NCBI GenBank. 368 
 369 
Table 2 Non-synonymous substitutions per non-synonymous site (KA) and 370 
synonymous substitutions per synonymous site (KS) averaged over the whole TLR2 371 
coding region, the leucine-rich repeat 9 – 14 region (LRR 9 – 14), where most of the 372 
pathogen-binding and dimerisation sites are situated  (Jin et al. 2007), the 373 
intracellular TIR domain and peak 1 and peak 2 identified in the sliding-window 374 
analysis (Fig. 1) for all species combined and the Murinae, Myodini and Arvicolini 375 
separately. Peak 1 and 2 are characterised by both high KA and low KS. 376 
 377 
Table 3 Results of PAML site-models and positively selected sites identified by 378 
empirical Bayes approaches. Parameters are p0 =  proportion of sites where ω < 1, 379 
p1 = proportion of sites where ω = 1 and p2 = proportion of sites where ω > 1 380 
(selection models only). For models M7, M8 and M8a, p and q represent parameters 381 
of the beta distribution. Positive selection was inferred if the posterior probability of ω 382 
> 1 for a site was 0.95 or higher (bold). Sites with a posterior probability of ω > 1 383 
between 0.50 – 0.949 are also shown (italic). We considered two different 384 
approaches to determine sites under selection, the naive-empirical Bayes and the 385 
Bayes-empirical Bayes method (Yang et al., 2005). A site was included if one or both 386 
of the approaches gave statistical support for the site. Amino acids correspond to the 387 
Mus musculus sequence. 388 
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Figure legends 389 
 390 
Fig. 1 Signatures of positive selection on TLR2. Sliding window analysis of the ratio 391 
of non-synonymous substitutions per non-synonymous site (KA) to synonymous 392 
substitutions per synonymous  site (KS) along the entire coding region of the TLR2 393 
gene of A) all species combined, and B) Murinae, C) Myodini and D) Arvicolini 394 
separately compared to Cavia porcellus (window size 30 bp, step size 10 bp). A ratio 395 
> 1 is indicative of positive selection. Note the different scales on the y-axes. The 396 
schema of the functional domains and the putative positions of the pathogen-binding 397 
and TLR2 – TLR1 heterodimerisation sites are based on Gautam et al. (2006), Jin et 398 
al. (2007), and Jann et al. (2008). The positively selected site (PSS) identified by 399 
empirical Bayes approaches is shown in red. LRR: leucine-rich repeat, TM: 400 
transmembrane domain, TIR: Toll/ Interleukin-1 receptor domain. 401 
 402 
Fig. 2 Expected ω of codons along the TLR2 sequence. Estimates are based on 403 
Naive empirical Bayes probabilities for three classes. 404 
405 
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